Lifeline BioTechnologies, Inc. in Discussions with Firms to Begin Filing FDA 510(k) Submission for First Warning System(TM)

RENO, Nev.--(BUSINESS WIRE)--Lifeline Biotechnologies, Inc. (Pink Sheets:LLBT) today announced that the Company has been in discussions with various firms to help with the preparation of filing the 510(k) with the U.S. Food and Drug Administration (FDA). The selected firm will help with the verification and validation guidelines, and the Company expects to announce its selection soon.